Partially based on research at Duke University, Camras Vision is working on a treatment for refractory glaucoma.
Camras Vision, a US-based medical device manufacturer exploiting research from Duke University, raised $5.7m in a series A round on Monday co-led by VCapital, InFocus Capital Partners and Triangle Venture Alliance.
Triangle Angel Partners, IMAF Coastal Plain, Pilot Mountain Ventures and assorted angel investors also took part in the round.
Camras Vision is developing a therapy for glaucoma, a condition that causes pressure to build up in the eye and leads to blindness. Patients are currently treated through a combination…
